Ignite Creation Date:
2025-12-24 @ 5:50 PM
Ignite Modification Date:
2026-04-09 @ 4:44 AM
Study NCT ID:
NCT01495468
Status:
COMPLETED
Last Update Posted:
2017-07-31
First Post:
2011-12-16
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase III Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children
Sponsor:
Changchun GeneScience Pharmaceutical Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-03
Start Date Type:
None
Primary Completion Date:
2008-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-03
Completion Date Type:
ACTUAL
First Submit Date:
2011-12-16
First Submit QC Date:
None
Study First Post Date:
2011-12-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-07-27
Last Update Post Date:
2017-07-31
Last Update Post Date Type:
ACTUAL